BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 16806840)

  • 1. Proteolytic cleavage of Livin (ML-IAP) in apoptotic melanoma cells potentially mediated by a non-canonical caspase.
    Yan H; Brouha B; Liu T; Raj D; Biddle D; Lee R; Grossman D
    J Dermatol Sci; 2006 Sep; 43(3):189-200. PubMed ID: 16806840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspase-mediated cleavage converts Livin from an antiapoptotic to a proapoptotic factor: implications for drug-resistant melanoma.
    Nachmias B; Ashhab Y; Bucholtz V; Drize O; Kadouri L; Lotem M; Peretz T; Mandelboim O; Ben-Yehuda D
    Cancer Res; 2003 Oct; 63(19):6340-9. PubMed ID: 14559822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis.
    Yang QH; Church-Hajduk R; Ren J; Newton ML; Du C
    Genes Dev; 2003 Jun; 17(12):1487-96. PubMed ID: 12815069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoform-specific silencing of the Livin gene by RNA interference defines Livin beta as key mediator of apoptosis inhibition in HeLa cells.
    Crnković-Mertens I; Semzow J; Hoppe-Seyler F; Butz K
    J Mol Med (Berl); 2006 Mar; 84(3):232-40. PubMed ID: 16437214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas.
    Vucic D; Stennicke HR; Pisabarro MT; Salvesen GS; Dixit VM
    Curr Biol; 2000 Nov; 10(21):1359-66. PubMed ID: 11084335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mitochondrial serine protease HtrA2/Omi cleaves RIP1 during apoptosis of Ba/F3 cells induced by growth factor withdrawal.
    Vande Walle L; Wirawan E; Lamkanfi M; Festjens N; Verspurten J; Saelens X; Vanden Berghe T; Vandenabeele P
    Cell Res; 2010 Apr; 20(4):421-33. PubMed ID: 20125124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways.
    Suzuki Y; Takahashi-Niki K; Akagi T; Hashikawa T; Takahashi R
    Cell Death Differ; 2004 Feb; 11(2):208-16. PubMed ID: 14605674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of dual apoptotic pathways in human melanocytes and protection by survivin.
    Liu T; Biddle D; Hanks AN; Brouha B; Yan H; Lee RM; Leachman SA; Grossman D
    J Invest Dermatol; 2006 Oct; 126(10):2247-56. PubMed ID: 16728972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Livin, a novel inhibitor of apoptosis protein family member.
    Kasof GM; Gomes BC
    J Biol Chem; 2001 Feb; 276(5):3238-46. PubMed ID: 11024045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcellular localization determines the delicate balance between the anti- and pro-apoptotic activity of Livin.
    Nachmias B; Lazar I; Elmalech M; Abed-El-Rahaman I; Asshab Y; Mandelboim O; Perlman R; Ben-Yehuda D
    Apoptosis; 2007 Jul; 12(7):1129-42. PubMed ID: 17294084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the Omi/HtrA2 signaling pathway after transient focal cerebral ischemia in mouse brains that overexpress SOD1.
    Saito A; Hayashi T; Okuno S; Nishi T; Chan PH
    Brain Res Mol Brain Res; 2004 Aug; 127(1-2):89-95. PubMed ID: 15306124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the truncated form of Livin reveals a complex interaction with caspase-3.
    Liu GH; Wang C; Ding ZY
    Int J Oncol; 2013 Jun; 42(6):2037-45. PubMed ID: 23563149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding specificity and regulation of the serine protease and PDZ domains of HtrA2/Omi.
    Martins LM; Turk BE; Cowling V; Borg A; Jarrell ET; Cantley LC; Downward J
    J Biol Chem; 2003 Dec; 278(49):49417-27. PubMed ID: 14512424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and role of the inhibitor of apoptosis protein livin in chemotherapy sensitivity of ovarian carcinoma.
    Liu X; Wang A; Gao H; Yuan Z; Jiao Y
    Int J Oncol; 2012 Sep; 41(3):1021-8. PubMed ID: 22766624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitor of apoptosis protein Livin (ML-IAP) plays a dual role in tumorigenicity.
    Abd-Elrahman I; Hershko K; Neuman T; Nachmias B; Perlman R; Ben-Yehuda D
    Cancer Res; 2009 Jul; 69(13):5475-80. PubMed ID: 19549891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A serine protease is involved in the initiation of DNA damage-induced apoptosis.
    de Bruin EC; Meersma D; de Wilde J; den Otter I; Schipper EM; Medema JP; Peltenburg LT
    Cell Death Differ; 2003 Oct; 10(10):1204-12. PubMed ID: 14502243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of livin gene expression by siRNA leads to growth inhibition and apoptosis induction in human bladder cancer T24 cells.
    Yang D; Song X; Zhang J; Ye L; Wang S; Che X; Wang J; Zhang Z; Wang L
    Biosci Biotechnol Biochem; 2010; 74(5):1039-44. PubMed ID: 20460713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
    Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P
    Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of the apoptotic machinery during megakaryocyte differentiation and platelet production by inhibitor of apoptosis protein Livin.
    Abd-Elrahman I; Deutsch V; Pick M; Kay S; Neuman T; Perlman R; Ben-Yehuda D
    Cell Death Dis; 2013 Nov; 4(11):e937. PubMed ID: 24287698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulation of NK cytotoxicity by the IAP family member Livin.
    Nachmias B; Mizrahi S; Elmalech M; Lazar I; Ashhab Y; Gazit R; Markel G; Ben-Yehuda D; Mandelboim O
    Eur J Immunol; 2007 Dec; 37(12):3467-76. PubMed ID: 18034418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.